CVRx, Inc.

NASDAQ:CVRX

Medical - Devices

Healthcare
$2.63 +2.28%

+$0.11 today

Market cap
$69.79M
Beta
0.77
P/E (TTM)
-2.5
EPS (TTM)
-$2.00
52W Low $4.37High $11.30

Volume 0.37M

Average 0.30M

Returns on capital

CVRx, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-135.6%

avg -47.4%

ROIC

-56.0%

avg -38.4%

ROA

-50.9%

avg -37.9%

Analysis

ROA is currently the strongest return metric at -50.9% versus its period average of -37.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Kevin Hykes

President, Chief Executive Officer & DirectorUSD 2.64M60284.24K1.07%

Philip Adamson

Chief Medical OfficerUSD 1.1M65——

Robert Allen John

Chief Revenue OfficerUSD 1.05M5286.04K0.32%

Paul Verrastro

Chief Marketing & Strategy OfficerUSD 598.97K6360.55K0.23%

Jared Oasheim

Chief Financial OfficerUSD 517.27K4396.70K0.36%

Bonnie Handke

Senior Vice President of Patient Access, Reimbursement, & Healthcare Economics————

Brent Binkowski

Chief Operating Officer—5756.51K0.21%

Gregory Morrison

Chief Human Resources Officer—620<0.01%

Compensation is shown in the reported currency; data updated Aug 29, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Aug 13, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

3

$376,809.04

Sells

11

$444,645.54

Net Transaction Value

−$67,836.50

Net selling

Most Active

JOHNSON & JOHNSON

5 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Aug 13, 26

Binkowski Brent

Direct

Buy$76.4K
Aug 12, 26

Binkowski Brent

Direct

Sell$3.3K
Mar 2, 26

OASHEIM JARED

Direct

Sell$13.8K
Mar 2, 26

Adamson Philip B.

Direct

Sell$10K
Mar 2, 26

John Robert Allen

Direct

Sell$31.3K
Mar 2, 26

VERRASTRO PAUL

Direct

Sell$10.1K
Mar 2, 26

Hykes Kevin

Direct

Sell$61.3K
Feb 20, 26

Jain Mudit K.

Indirect

Buy$297.6K
Feb 18, 26

Jain Mudit K.

Direct

Buy$2.8K
Nov 26, 25

JOHNSON & JOHNSON

Indirect

Sell$63.6K

1–10 of 14

Summary

Insiders reported 3 buys worth $376,809.04 and 11 sells worth $444,645.54 over the last 12 months. That adds up to net selling of $67,836.50. JOHNSON & JOHNSON was the most active insider with 5 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/A+36.1%
+16.8% (5yr)2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Recent growth has been strongest in Revenue at +36.1% over three years. Forward estimates point to Revenue at +16.8% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does CVRx, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about CVRX's management, answered from reported figures.

Who manages CVRX?

CVRx, Inc. (CVRX) lists 8 active executives. The top listed executive is Kevin Hykes, President, Chief Executive Officer & Director.

Are CVRX insiders buying or selling?

Recent insider activity shows net buying of $29.53M.